PECAM1 and neoplasm: Since characterisation of stromal heterogeneity represented the overarching goal of this study, dimensionality reduction of CD31− stroma FC counts was performed with tSNE for the eight patient-matched cohort to identify putative benign- or tumour-enriched stromal cell subpopulations (Figure 6; Supplementary Figure S6A).